FDA approves Narcan nasal spray, adds pediatric labeling

On November 18, the Food and Drug Administration (FDA) approved Narcan nasal spray. This is naloxone, used commonly in kits made up of vials of the medication along with a tube and syringe to get it into the nose. Unlike those kits, which are not approved by the FDA but are used off‐label, the Narcan spray comes in one package. Naloxone rescues people who have overdosed on opioids, reversing the effects. If administered within 2 minutes, it can save a life.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: From the FDA Source Type: research